23andMe Is Selling Its Customers’ Genetic Data to Drug Maker Regeneron: ‘The Power of Genetics and Data’

23andMe Is Selling Its Customers’ Genetic Data to Drug Maker Regeneron: ‘The Power of Genetics and Data’ 23andMe Is Selling Its Customers’ Genetic Data to Drug Maker Regeneron: ‘The Power of Genetics and Data’

The database includes DNA samples from about 15 million people.

Add a comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Keep Up to Date with our Weekly Newsletter

By pressing the Subscribe button, you confirm that you have read and are agreeing to our Privacy Policy and Terms of Use
Advertisement